Nukkleus INC

T3 Defense Inc. has amended its stock purchase agreement to acquire KeepZone AI Inc., increasing the purchase price and adjusting beneficial ownership limitations.

T3 Defense Inc. announced the consummation of a sale of 200 units for $10 million, consisting of Series B Convertible Preferred Stock and common stock purchase warrants, with net proceeds of $6.6 million after debt repayment and fees.

T3 Defense Inc. announced a definitive agreement to acquire KeepZone AI Inc., a homeland security technology distribution and integration company, to bolster its sales and business development capabilities.

T3 Defense Inc. announces it has regained compliance with Nasdaq's Stockholders' Equity Requirement following the exercise of common warrants.

T3 Defense Inc. has appointed Shlomo Zakai as its new Chief Financial Officer, effective October 5, 2026, under a consulting agreement.

T3 Defense Inc. has entered into a $3 million term note agreement with Esousa Group Holdings LLC, bearing a 1% monthly interest rate, with multiple maturity triggers.

T3 Defense Inc. filed its Q2 2026 10-Q, detailing significant revenue generation for the first time, but also reporting substantial net losses and ongoing liquidity challenges, while navigating strategic acquisitions and efforts to regain Nasdaq listing compliance.

T3 Defense Inc. reported Q1 2026 financial results, announced a strategic share exchange with VisionWave Holdings, and addressed a Nasdaq minimum bid price deficiency.

Nukkleus Inc. reports a strategic shift to defense and AI, divesting financial services while securing significant capital and pursuing multiple acquisitions, despite ongoing operational losses and internal control weaknesses.

Nukkleus Inc. reported a significant Q2 2025 net income driven by non-cash gains, as it strategically shifts from financial technology to the defense sector while facing substantial liquidity challenges.

Nukkleus Inc. filed an amendment to its quarterly report for the period ended March 31, 2025, to explicitly state that its disclosure controls and procedures were not effective due to material weaknesses in internal control over financial reporting.

Nukkleus Inc. reported a substantial net income for Q1 2025 driven by non-cash fair value adjustments of liabilities, as it continues its strategic shift from financial technology to the defense sector through the acquisition of Star 26 Capital Inc.

T3 Defense Inc. (formerly Nukkleus Inc.) has finalized its transformation into an aerospace and defense company, announcing several key acquisitions and a new strategic direction.

Nukkleus Inc. filed an amendment to its annual report, revealing that its internal controls over financial reporting were not effective as of December 31, 2024, due to identified material weaknesses.

Nukkleus Inc. is transitioning its business focus to the defense sector through the acquisition of Star 26 Capital, while also restructuring its finances and discontinuing certain operations.

Nukkleus Inc. files an amendment to its annual report to include information on its policy for recovering erroneously awarded compensation, while also detailing its business strategy, recent developments, and financial performance.

Nukkleus Inc. announces a strategic shift towards the defense sector by acquiring a controlling interest in Star 26 Capital, a defense acquisition company, while navigating financial challenges and restructuring its operations.

Nukkleus Inc.'s 10-K filing details service agreements with FML Malta and FXDirectDealer, alongside its financial performance and strategic shift towards blockchain-enabled technology solutions.

Menachem Shalom, Director and CEO of T3 Defense Inc., reported significant transactions involving common stock and warrants on April 27, 2026.

Nukkleus Inc. CEO Menachem Shalom exercised warrants to acquire 200,000 shares of common stock at $1.50 per share, increasing his direct ownership.

Nukkleus Inc. CEO Menachem Shalom increased his beneficial ownership of common stock and warrants following the acquisition of Star 26 Capital, Inc.

Anastasiia Kotaieva, a former director and 10% shareholder of Nukkleus Inc., has fully divested her remaining common stock holdings.

Anastasiia Kotaieva, a former director and 10% owner of Nukkleus Inc., reported selling 211,208 shares of common stock across four transactions in late December 2025.

Anastasiia Kotaieva, a former director and 10% owner of Nukkleus Inc., reported the sale of 108,744 shares of common stock in mid-December 2025 under a Rule 10b5-1 plan.

T3 Defense Inc. has issued a proxy statement detailing proposals for a new equity incentive plan, a reverse stock split, and a CEO award agreement, to be voted on at a special meeting on November 30, 2026.

T3 Defense Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for August 5, 2026, to be held virtually, with key proposals including director elections, auditor ratification, and the adoption of a new equity incentive plan.

T3 Defense Inc. is convening a special meeting of stockholders on June 18, 2026, to vote on crucial proposals including the issuance of shares related to warrants and preferred stock, and a potential reverse stock split to regain Nasdaq compliance.

Nukkleus Inc. announces the acquisition of 100% of Star, a related party, for $73.4 million, pivoting its business focus to the defense sector, subject to shareholder approval.

Nukkleus Inc. calls a Special Meeting to approve the acquisition of Star Capital 26, Inc., along with significant equity issuances for warrants and an equity line of credit, all requiring Nasdaq compliance.

Nukkleus Inc. announced its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and a new equity incentive plan, alongside details of a significant acquisition of Star, a defense and technology company.

T3 Defense Inc. files an S-1MEF to register an additional 1,951,799 shares for resale by selling stockholders, primarily from convertible preferred stock and warrants.

T3 Defense Inc. has filed an amendment (Amendment No. 2) to its Form S-1 Registration Statement, primarily to include additional exhibits.

T3 Defense Inc. has filed an amendment to its S-1 registration statement, primarily to include exhibits and a legal opinion regarding the issuance of common stock.

T3 Defense Inc. has filed an amendment to its S-1 registration statement to facilitate the resale of up to 30 million shares of common stock by selling stockholders.

T3 Defense Inc., formerly a financial technology firm, is transforming into an aerospace and defense acquirer and operator, facing significant operational and financial challenges while registering shares for resale by existing investors.

T3 Defense Inc. (formerly Nukkleus Inc.) has completed a strategic transformation from financial technology to aerospace and defense, marked by several acquisitions and a significant capital raise.

Tessera Defense & Homeland Security Inc. (formerly BiomX Inc.) has filed an exit statement on Schedule 13D, confirming partial share issuance and principal payments while a significant portion of shares remains subject to stockholder approval.

X S.E. Security and Defense Ltd. and Elad Shohat have jointly filed a Schedule 13D, disclosing beneficial ownership of 168,479 shares, representing 16.67% of T3 Defense Inc.'s common stock.

Menachem Shalom has increased his beneficial ownership in T3 Defense Inc. to 25.4% through warrant exercises and note conversions, as detailed in an amended Schedule 13D filing.

An amendment to a Schedule 13D filing reveals that Menachem Shalom, along with affiliated entities, now beneficially owns 20.4% of BiomX Inc. common stock following a business acquisition.

BiomX Inc. has acquired Zorro Net Ltd., a visual AI and computer vision technology firm, from Water IO Ltd. for 1.3 million shares of BiomX common stock and a $1.25 million promissory note.

Nukkleus Inc.'s CEO, Menachem Shalom, has increased his beneficial ownership to 26.0% and entered into a call option agreement to potentially repurchase shares from Esousa Group Holdings LLC.

VisionWave Holdings, Inc. has reported beneficial ownership of 6,000,000 shares, representing 9.96% of T3 Defense Inc.'s common stock, as of May 17, 2026.

Esousa Group Holdings LLC and Michael Wachs have disclosed a 9.9% beneficial ownership stake in Nukkleus Inc., primarily through convertible preferred stock and warrants.

Esousa Group Holdings LLC and Michael Wachs have disclosed a continued beneficial ownership of 9.99% in Nukkleus Inc., comprising common stock, pre-funded warrants, and warrants.

Esousa Group Holdings LLC and Michael Wachs have filed an amended Schedule 13G, revealing a beneficial ownership of 9.99% in Nukkleus Inc.'s common stock as of December 31, 2024.